BIOTRONIK ’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK won FDA approval for its Orsiro drug-eluting coronary stent, an ultrathin device that’s already been approved in Europe for eight years and has been implanted in more than a million patients worldwide.
The Orsiro is a cobalt chromium ...

Source: Medgadget - February 25, 2019 Category: Medical Devices Authors: Editors Tags: Cardiology Source Type: blogs